Evidence map›Paper›PMID 41132527›Full record

ArticleFrontiers in pharmacology2025

Public attitudes towards the implementation of pharmaceutical care services in community pharmacies - a 2025 nationwide cross-sectional survey among adults in Poland.

Iwona Wrześniewska-Wal, Kuba Sękowski, Andrzej Silczuk, Mateusz Jankowski, Justyna Grudziąż-Sękowska

Abstract read
In one paragraph

Article in Frontiers in pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Iwona Wrześniewska-WalSchool of Public Health, Centre of Postgraduate Medical Education, Warsaw, Poland.
Kuba SękowskiSchool of Public Health, Centre of Postgraduate Medical Education, Warsaw, Poland.
Andrzej SilczukDepartment of Community Psychiatry, Medical University of Warsaw, Warsaw, Poland.
Mateusz JankowskiSchool of Public Health, Centre of Postgraduate Medical Education, Warsaw, Poland.
Justyna Grudziąż-SękowskaSchool of Public Health, Centre of Postgraduate Medical Education, Warsaw, Poland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Pharmacists, as healthcare professionals, can improve treatment outcomes by providing pharmaceutical care services and implementing adherence-supporting tools. In Poland, these services are still at an early stage of development, and data on public attitudes toward them remain limited. Methods: A nationwide cross-sectional survey was conducted using the computer-assisted web interviews (CAWI) method on a stratified sample of 1,102 adults, representative in terms of gender, age, and place of residence. A validated questionnaire was used to assess attitudes toward pharmaceutical care services and adherence-supporting interventions. Sociodemographic and health-related factors were analyzed using multivariable logistic regression. Results: Attitudes toward pharmaceutical care were positive. The most frequently accepted services included drug interaction review (85.5%), explanation of dosing for new medications (83.5%), and monitoring therapy with previously unused medications (69.4%). Among adherence-supporting tools, instruction labels (85.5%) and simplified leaflets with pictograms (80.7%) were rated highest, followed by SMS or email reminders (59.2%) and additional pharmacist contact (46.7%-53.7%). Significant sociodemographic differences emerged: men more often valued shortened leaflets (83.1% vs. 77.8%), instruction labels (87.6% vs. 83.0%), and pharmacist follow-up (46.9% vs. 40.3%); respondents ≥60 years favored leaflets (85.2%) and labels (89.2%); parents more frequently accepted labels (87.8% vs. 81.6%). Higher education and better economic status were linked to more positive views of pharmaceutical care. Participants with chronic diseases more frequently accepted dosing explanations (86.1% vs. 80.4%), monitoring of new drugs (72.1% vs. 66.1%), and interaction reviews (88.1% vs. 82.2%), with diabetes or prediabetes emerging as the strongest predictor of positive attitudes. In multivariable analysis, male gender (aOR = 1.40; 95% CI = 1.10-1.79; p = 0.007) and good (aOR = 1.52; 95% CI = 1.04-2.21; p = 0.03) or average economic status (aOR = 1.64; 95% CI = 1.11-2.41; p = 0.01) were significantly associated with interest in free pharmacist consultations. Having children (aOR = 1.60; 95% CI = 1.15-2.23; p = 0.005) and occupational activity (aOR = 1.37; 95% CI = 1.03-1.81; p = 0.03) increased the likelihood of believing that a pharmacist consultation after receiving a prescription facilitates correct medication use. Conclusion: Implementing pharmacist consultations alongside simple adherence tools may significantly improve medication safety and treatment effectiveness in patients with chronic conditions.

Indexed as

chronic diseasescommunity pharmacymedical educationmedication adherencepharmaceutical carepharmacists

Identifiers

PMID41132527
PMCPMC12541213

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.